Total Payments
$1,734
2024 Payments
$154.49
Companies
10
Transactions
34
Medicare Patients
3,449
Medicare Billing
$641,729
Payment Breakdown by Category
Food & Beverage$1,669 (96.3%)
Other$65.00 (3.7%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,669 | 33 | 96.3% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $65.00 | 1 | 3.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Dexcom, Inc. | $911.03 | 16 | $0 (2024) |
| AbbVie, Inc. | $328.67 | 5 | $0 (2019) |
| Novo Nordisk Inc | $156.89 | 3 | $0 (2024) |
| Amgen Inc. | $135.81 | 2 | $0 (2019) |
| SANOFI-AVENTIS U.S. LLC | $85.38 | 2 | $0 (2018) |
| Abbott Laboratories | $28.08 | 2 | $0 (2019) |
| Becton, Dickinson and Company | $25.77 | 1 | $0 (2017) |
| Ascensia Diabetes Care US Inc. | $21.96 | 1 | $0 (2017) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $20.36 | 1 | $0 (2017) |
| Novartis Pharmaceuticals Corporation | $20.34 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $154.49 | 2 | Dexcom, Inc. ($137.16) |
| 2023 | $287.46 | 5 | Dexcom, Inc. ($165.58) |
| 2022 | $157.10 | 1 | Dexcom, Inc. ($157.10) |
| 2021 | $114.23 | 1 | DEXCOM, INC. ($114.23) |
| 2019 | $390.42 | 6 | Dexcom, Inc. ($146.30) |
| 2018 | $266.43 | 4 | AbbVie, Inc. ($201.43) |
| 2017 | $364.16 | 15 | Dexcom, Inc. ($190.66) |
All Payment Transactions
34 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/12/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $17.33 | General |
| Category: Diabetes | ||||||
| 10/28/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $137.16 | General |
| Category: Endocrinology | ||||||
| 09/21/2023 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $17.34 | General |
| Category: Endocrinology | ||||||
| 07/05/2023 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $123.25 | General |
| Category: Endocrinology | ||||||
| 05/16/2023 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $121.88 | General |
| 03/08/2023 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $14.43 | General |
| Category: Endocrinology | ||||||
| 01/13/2023 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $10.56 | General |
| Category: Endocrinology | ||||||
| 08/09/2022 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $157.10 | General |
| Category: Endocrinology | ||||||
| 09/29/2021 | DEXCOM, INC. | DEXCOM G6 TRANSMITTER (Device) | Food and Beverage | In-kind items and services | $114.23 | General |
| Category: ENDOCRINOLOGY | ||||||
| 07/25/2019 | Amgen Inc. | EVENITY (Biological) | Food and Beverage | In-kind items and services | $114.02 | General |
| Category: Bone Health | ||||||
| 07/16/2019 | Dexcom, Inc. | DEXCOM CGM (Device) | Food and Beverage | In-kind items and services | $87.47 | General |
| Category: ENDOCRINOLOGY | ||||||
| 06/27/2019 | Abbott Laboratories | FreeStyle Libre (Device) | Food and Beverage | In-kind items and services | $15.10 | General |
| Category: Diabetes Care | ||||||
| 06/18/2019 | AbbVie, Inc. | — | Food and Beverage | In-kind items and services | $115.00 | General |
| 05/14/2019 | Dexcom, Inc. | DEXCOM CGM (Device) | Food and Beverage | In-kind items and services | $41.40 | General |
| Category: ENDOCRINOLOGY | ||||||
| 02/19/2019 | Dexcom, Inc. | DEXCOM CGM (Device) | Food and Beverage | In-kind items and services | $17.43 | General |
| Category: ENDOCRINOLOGY | ||||||
| 07/26/2018 | AbbVie, Inc. | Synthroid (Drug) | Food and Beverage | In-kind items and services | $96.26 | General |
| Category: Endocrinology | ||||||
| 06/28/2018 | AbbVie, Inc. | Synthroid (Drug) | Food and Beverage | In-kind items and services | $5.72 | General |
| Category: Endocrinology | ||||||
| 05/19/2018 | SANOFI-AVENTIS U.S. LLC | SOLIQUA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $65.00 | General |
| Category: DIABETES | ||||||
| 04/11/2018 | AbbVie, Inc. | Synthroid (Drug) | Food and Beverage | In-kind items and services | $99.45 | General |
| Category: Endocrinology | ||||||
| 08/18/2017 | Abbott Laboratories | CardioMEMS HF System (Device) | Food and Beverage | In-kind items and services | $12.98 | General |
| Category: Cardiac Arrhythmias and Heart Failure | ||||||
| 07/20/2017 | Dexcom, Inc. | Dexcom G5 Mobile CGM System (Device) | Food and Beverage | In-kind items and services | $10.61 | General |
| Category: Diabetes | ||||||
| 06/29/2017 | Dexcom, Inc. | Dexcom G5 Mobile CGM System (Device) | Food and Beverage | In-kind items and services | $10.72 | General |
| Category: Diabetes | ||||||
| 06/20/2017 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $20.34 | General |
| Category: CARDIOVASCULAR | ||||||
| 06/12/2017 | AbbVie, Inc. | Synthroid (Drug) | Food and Beverage | In-kind items and services | $12.24 | General |
| Category: Endocrinology | ||||||
| 05/23/2017 | Dexcom, Inc. | Dexcom G5 Mobile CGM System (Device) | Food and Beverage | In-kind items and services | $99.65 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 918 | 7,299 | $403,097 | $184,174 |
| 2022 | 12 | 939 | 6,703 | $383,119 | $164,338 |
| 2021 | 12 | 830 | 6,281 | $375,941 | $166,582 |
| 2020 | 11 | 762 | 5,285 | $317,869 | $126,635 |
Total Patients
3,449
Total Services
25,568
Medicare Billing
$641,729
Procedure Codes
49
All Medicare Procedures & Services
49 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 61 | 5,880 | $207,360 | $106,041 | 51.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 305 | 531 | $103,014 | $49,636 | 48.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 43 | 43 | $13,373 | $5,130 | 38.4% |
| 95251 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | Office | 2023 | 73 | 165 | $19,965 | $4,358 | 21.8% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 16 | 53 | $7,685 | $3,396 | 44.2% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 180 | 344 | $19,952 | $3,275 | 16.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 20 | 22 | $5,896 | $2,974 | 50.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 35 | 38 | $4,674 | $2,623 | 56.1% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2023 | 16 | 18 | $4,500 | $1,929 | 42.9% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 15 | 15 | $3,810 | $1,648 | 43.3% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 56 | 84 | $5,880 | $992.68 | 16.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 11 | 11 | $2,255 | $885.39 | 39.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 76 | 84 | $2,940 | $705.60 | 24.0% |
| 95249 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin | Office | 2023 | 11 | 11 | $1,793 | $579.92 | 32.3% |
| J0897 | Injection, denosumab, 1 mg | Office | 2022 | 51 | 5,280 | $185,760 | $86,300 | 46.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 306 | 527 | $102,238 | $48,815 | 47.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 53 | 53 | $16,483 | $6,322 | 38.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 40 | 44 | $11,792 | $5,958 | 50.5% |
| 95251 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | Office | 2022 | 65 | 141 | $17,061 | $3,926 | 23.0% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 202 | 367 | $21,286 | $3,522 | 16.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 42 | 43 | $5,289 | $2,876 | 54.4% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 14 | 46 | $6,670 | $2,397 | 35.9% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2022 | 13 | 16 | $4,000 | $1,607 | 40.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 19 | 19 | $3,895 | $1,377 | 35.4% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 48 | 80 | $5,600 | $981.67 | 17.5% |
About Aileen Westrick
Aileen Westrick is a Endocrinology, Diabetes & Metabolism healthcare provider based in Carol Stream, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/20/2009. The National Provider Identifier (NPI) number assigned to this provider is 1770710493.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Aileen Westrick has received a total of $1,734 in payments from pharmaceutical and medical device companies, with $154.49 received in 2024. These payments were reported across 34 transactions from 10 companies. The most common payment nature is "Food and Beverage" ($1,669).
As a Medicare-enrolled provider, Westrick has provided services to 3,449 Medicare beneficiaries, totaling 25,568 services with total Medicare billing of $641,729. Data is available for 4 years (2020–2023), covering 49 distinct procedure/service records.
Ad
Practice Information
- Specialty Endocrinology, Diabetes & Metabolism
- Other Specialties Diabetes & Metabolism
- Location Carol Stream, IL
- Active Since 06/20/2009
- Last Updated 12/18/2014
- Taxonomy Code 207RE0101X
- Entity Type Individual
- NPI Number 1770710493
Products in Payments
- Dexcom G6 Transmitter (Medical Supply) $459.84
- Synthroid (Drug) $213.67
- Dexcom G5 Mobile CGM System (Device) $190.66
- DEXCOM CGM (Device) $146.30
- DEXCOM G6 TRANSMITTER (Device) $114.23
- EVENITY (Biological) $114.02
- SOLIQUA (Drug) $85.38
- BD Nano (Device) $25.77
- CONTOUR NEXT Test Strips (Device) $21.96
- Corlanor (Drug) $21.79
- JARDIANCE (Drug) $20.36
- ENTRESTO (Drug) $20.34
- Ozempic (Drug) $17.33
- FreeStyle Libre (Device) $15.10
- CardioMEMS HF System (Device) $12.98
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.